New Endometriosis Pill Approved by NHS, Offering New Hope for Patients
The NHS has approved the first one-a-day tablet to treat endometriosis long-term, a painful condition that approximately 1.5 million women in the UK live with. The new drug, relugolix-estradiol-norethisterone or Ryeqo, could transform patients’ lives with a more straightforward and efficient treatment. Endometriosis occurs when tissue lining the womb is discovered outside the womb, leading…